期刊文献+

合成纳米铝佐剂及其对乙型肝炎、狂犬病毒辅佐效应的研究 被引量:14

Synthesis of nanoparticulate alum adjuvant and its application to the HBsAg and rabies virus
下载PDF
导出
摘要 目的通过自制纳米铝佐剂,研究其对乙型肝炎病毒和狂犬病毒的体液免疫应答。方法在25℃条件下,采用微乳液法制备纳米铝佐剂。与常规铝佐剂比较,经皮下注射豚鼠和Balb/c小鼠后,于不同的时间测定血清中特异性IgG抗体的效价。结果透射电镜(TEM)和差式量热扫描(DSC),可知产物为平均粒径约为72.62 nm,近球形的Al(OH)3结晶颗粒。纳米铝佐剂辅佐的HBsAg,在免疫Balb/c小鼠后第1周和第2周的血清抗体滴度明显高于常规铝佐剂组(P<0.01;P<0.05);纳米铝佐剂辅佐的狂犬疫苗,其特异性IgG抗体效价高于常规铝佐剂组,并且在免疫后的第7天,抗体就呈现出阳性(P<0.05)。结论纳米铝佐剂在诱导HBsAg和Rabies疫苗体液免疫应答的早期优于目前的常规铝佐剂,能够快速地激活和提高Balb/c小鼠和豚鼠的免疫应答和应答水平。 Objective To study the humoral immunity changes induced by HBsAg and rabies virus absorbed onto domestic nanoparticulate alum adjuvant. Methods Nanoparticulate alum adjuvant had been synthesized by the microemulsion at 25 ℃, Tne specific antibody titers of IgG in Guinea pigs and Balb/c mice were assayed after hypodermic injection of nanopartieulate alum adjuvant, and then compared with those of normal alum adjuvant. Results By the .analyses of transmission electron microscopy (TEM) and differential scanning calorimetery (DSC), the resultant particle was characterized to be the AI(OH)3 crystal, which was a spherical structure of 70 nm in diameter. Serum anti-HBsAg IgG titers of nanoparticulate alum adjuvant group were higher than those of bulk alum adjuvant group in the first two weeks after immunization ( P 〈 0.01 ; P 〈 0.05) ; The anit-rabies virus IgG titers of nanoparticulate alum adjuvant group was higher than those of control group ( P 〈 0.05), and the antibody presented positive at 7 d postimmunization. Conclusion With assist of nanoparticulate alum adjuvant, HBsAg and rabies virus can induce higher and earlier humoral immunity compared with assist of bulk alum adjuvant.
出处 《免疫学杂志》 CAS CSCD 北大核心 2006年第1期90-93,共4页 Immunological Journal
基金 国家自然科学基金资助项目(30170884)
关键词 纳米铝佐剂 微乳液 乙型肝炎疫苗 狂犬疫苗 体液免疫 Nanoparticulate alum adjuvant Microemulsion Hepatitis B surface antigen Rabies virus Humoral immunity
  • 相关文献

参考文献11

  • 1He Q,Mitchell AR,Johnson SL,et al.Calcium phosphate nanoparticle adjuvant[J].Clin Diagn Lab Immunol,2000,7(6):899-903.
  • 2Gupta RK,Rost BE,Relyveld E,et al.Adjuvant properties of aluminum and calcium compounds[J].Pharm Biotechnol,1995,6:229-248.
  • 3Duclos P.Safety of immunisation and adverse events following vaccination against hepatitis B[ J ].Expert Opin Drug Saf,2003,2 (3):225-231.
  • 4Bordet AL,Michenet P,Cohen C,et al.Post-vaccination granuloma due to aluminium hydroxide[ J ].Ann Pathol,2001,21 (2):149-152
  • 5何萍,吕凤林,任建敏,何凤慈.铝佐剂机制及其纳米化前景[J].世界华人消化杂志,2003,11(11):1764-1768. 被引量:18
  • 6Haviv J,Rishpon S,Gdalevich M,et al.Successful postexposure rabies prophylaxis after erroneous starting treatment[J].Prev Med,1999,29 (1):28-31.
  • 7Hanlon CA,Niezgoda M,Morrill PA,et al.The incurable wound revisited:progress in human rabies prevention?[J].Vaccine,2001,19 (17/19):2 273-2 279.
  • 8吕凤林,何凤慈.利用纳米材料制作多肽疫苗佐剂的思考[J].生物化学与生物物理进展,2001,28(6):832-835. 被引量:24
  • 9Raghuvanshi RS,Katare YK,Lalwani K,et al.Improved immune response from biodegradable polymer particles entraiepping tetanus toxoid by use of different immunization protocol and adjuvants[J].Int J Pharm,2002,245(1/2):109-121.
  • 10Tobio M,Sachwendeman SP,Guy Y,et al.Improved immunogenicity of a core coated tetanus toxoid delivery system[J].Vaccine,1999,18 (7/8):618-622.

二级参考文献10

共引文献39

同被引文献282

引证文献14

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部